Literature DB >> 24790340

The circadian variation of cortisol secretion in patients with anorexia nervosa in childhood and adolescence after recovery of body weight by treatment using gas chromatography/mass spectrometry in selected ion monitoring.

Keiko Homma1, Akihiro Sato2, Hisako Watanabe2, Tomonobu Hasegawa2.   

Abstract

Anorexia nervosa (AN) is a chronic psychiatric disorder which is characterized by patient-induced weight loss. Complications in many organ systems can be seen in AN such as cardiovascular, gastrointestinal, and endocrine system including hypothalamic-pituitary-adrenal axis, even after recovery of body weight by treatment. Urinary steroid profile analysis using gas chromatography/mass spectrometry (GC/MS) in selected ion monitoring (SIM) has been reported to be useful for the diagnosis of abnormal steroidogenesis in newborn infants, childhood, and adults. The aim of this study was to analyze the circadian variation of cortisol secretion in patients with anorexia nervosa (AN) in childhood and adolescence after recovery of body weight by treatment using GC/MS in SIM. The subjects were 7 healthy young adults (20-23 yr of age, BMI 19.7-24.8 kg/m(2)) and 5 AN patients in childhood and adolescence (13-19 yr of age), who had recovered body weight by treatment (BMI 15.4-19.3 kg/m(2); 3(rd)-25(th) to 50(th) percentile). Urine samples were collected for 26 hours (from 21:00 to 23:00 next day) at each urination. In each sample, the cortisol metabolites were measured by GC/MS in SIM. The sum of all cortisol metabolites was calculated as mg/g creatinine. In all 5 AN patients in childhood and adolescence, the circadian variation of the sum of cortisol metabolites was observed and was similar to that in healthy young adults. Although our data are preliminary, in patients with AN in childhood and adolescence, who have recovered body weight by treatment, the circadian variation of cortisol secretion may be conserved.

Entities:  

Keywords:  GC/MS-SIM; adolescence; anorexia nervosa; childhood; circadian variation; cortisol

Year:  2007        PMID: 24790340      PMCID: PMC4004895          DOI: 10.1297/cpe.16.17

Source DB:  PubMed          Journal:  Clin Pediatr Endocrinol        ISSN: 0918-5739


Introduction

Anorexia nervosa (AN) is a chronic psychiatric disorder which is characterized by patient-induced weight loss. Recently AN has been an important health concern among childhood and adolescence in advanced countries. AN in childhood and adolescence can have medical complications in many organ systems such as cardiovascular, gastrointestinal, and the endocrine system, which might persist even after recovery of body weight. A number of endocrine systems can be abnormal including for example appetite-regulating peptides, monoaminergic systems, the hypothalamic-pituitary-adrenal axis, the hypothalamic-pituitary-ovarian axis, the hypothalamic-growth hormone -insulin-like growth factor I (IGF-l) axis, the hypothalamic-pituitary-thyroid axis, and the bone metabolism (1,2,3,4,5). Urinary steroid profile analysis using gas chromatography/mass spectrometry (GC/MS) in selected ion monitoring (SIM) has been reported to be useful in the diagnosis of abnormal steroidogenesis in newborn infants, childhood, and adults (6,7,8). An altered circadian variation of cortisol secretion is assumed to be characteristic for some chronic psychiatric disorders (9, 10). Therefore, the aim of this study was to analyze circadian variation of cortisol secretion using the sum of cortisol metabolites in urine by GC/MIS in SIM in patients with AN in childhood and adolescence after recovery of body weight by treatment.

Subjects and Methods

The subjects were 7 healthy young adults (20–23 yr of age, 6 female and 1 male, BMI 19.7–24.8 kg/m2) and 5 AN patients undergoing treatment in childhood and adolescence (13–19 yr of age, all female). Diagnosis of AN was based on the diagnostic criteria for AN in childhood and adolescence (11). All patients had been treated by the “Keio Method” (comprehensive multi-modal program focused on retrieval of healthy adolescent growth and development) for more than one year (12). The BMI of the patients were 15.4–19.3 kg/m2; 3rd–25th to 50th percentile (Table 1) (13). All subjects gave their informed consent for this study.
Table 1

Five AN patients undergoing treatment

The subjects urinated ad lib. Urine samples were collected for 26 h (from 21:00 to 23:00 next day) at each urination to investigate the circadian variation of cortisol secretion. Each sample was kept at –20°C until analyzed. In each sample, the cortisol metabolites were measured (5β-tetrahydrocortisol, 5α-tetrahydrocortisol, 5β-tetrahydrocortisone, and 5α-tetrahydrocortisone) according to methods previously reported (7, 8). In brief, the method consisted of enzymatic hydrolysis of urine sample, extraction, derivative formation, purification, GC/MS-SIM analysis, and quantification. The sum of 5β-tetrahydrocortisol, 5α-tetrahydrocortisol, 5β-tetrahydrocortisone, and 5α-tetrahydrocortisone was calculated as mg/g creatinine.

Results

Healthy young adults

All 7 healthy young adults showed circadian variation of the sum of cortisol metabolites. The levels of the sum were highest on waking, gradually declining throughout the day, and reaching nadir in the evening (Fig. 1). The tentative reference range of the sum of cortisol metabolites is shown in Fig. 2.
Fig. 1

The sum of cortisol metabolites in healthy young adults. The sum of 5β-tetrahydrocortisol, 5α-tetrahydrocortisol, 5β-tetrahydrocortisone and 5α-tetrahydrocortisone was calculated and plotted for each of the seven healthy young adults. Lower panel shows the sleep-wake patterns, which were recorded by the subjects. The gray scale indicates waking hours.

Fig. 2

The tentative reference range of the sum of cortisol metabolites. The maximum to the minimum of the sum was tentatively defined as the reference range and marked using oblique lines.

The sum of cortisol metabolites in healthy young adults. The sum of 5β-tetrahydrocortisol, 5α-tetrahydrocortisol, 5β-tetrahydrocortisone and 5α-tetrahydrocortisone was calculated and plotted for each of the seven healthy young adults. Lower panel shows the sleep-wake patterns, which were recorded by the subjects. The gray scale indicates waking hours. The tentative reference range of the sum of cortisol metabolites. The maximum to the minimum of the sum was tentatively defined as the reference range and marked using oblique lines.

AN in childhood and adolescence after recovery of body weight by treatment

(Fig. 3)
Fig. 3

The sum of cortisol metabolites in patients with AN in childhood and adolescence. The sum of 5β-tetrahydrocortisol, 5α-tetrahydrocortisol, 5β-tetrahydrocortisone and 5α-tetrahydrocortisone was calculated for the 5 patients with AN in childhood and adolescence. The data were plotted on the tentative reference range (Fig. 2). The arrow indicates Case 5. Lower panel shows the sleep-wake patterns, which were recorded by the subjects.

The sum of cortisol metabolites in patients with AN in childhood and adolescence. The sum of 5β-tetrahydrocortisol, 5α-tetrahydrocortisol, 5β-tetrahydrocortisone and 5α-tetrahydrocortisone was calculated for the 5 patients with AN in childhood and adolescence. The data were plotted on the tentative reference range (Fig. 2). The arrow indicates Case 5. Lower panel shows the sleep-wake patterns, which were recorded by the subjects. All 5 patients with AN in childhood and adolescence showed circadian variation of the sum of cortisol metabolites, being highest on waking, gradually declining throughout the day, and reaching nadir in the evening, the same as in healthy young adults. In 4 out of 5 patients, the circadian variation was within the tentative reference range. One patient showed a somewhat low sum of cortisol metabolites during the daytime.

Discussion

We successfully analyzed the possible circadian variation of cortisol secretion in healthy young adults as well as patients with anorexia nervosa in childhood and adolescence after recovery of body weight by treatment using the sum of cortisol metabolites in urine using GC/MS in SIM. As far as we know, this is the first study on circadian variation of cortisol secretion as measured by GC/MS-SIM in any setting. Healthy young adults showed circadian variation of cortisol secretion, it being highest on waking, gradually declining throughout the day, and reaching nadir in the evening, which was consistent with a previous study showing circadian rhythm of plasma cortisol levels (14). The sum of cortisol metabolites in urine using GC/MS in SIM can be clinically applicable to subjects with any kind of disease considering its non-invasiveness and ease of collection compared to frequent blood sampling. Our study indicates that patients with AN in childhood and adolescence after recovery of body weight by treatment showed the same circadian variation of cortisol secretion, as in healthy young adults. Little has been known about circadian variation of cortisol secretion in patients with AN in childhood and adolescence. Gold et al. reported that the circadian variation of plasma cortisol level in patients with AN in childhood and adolescence was conserved, while its level was often high (15). In terms of the circadian variation of cortisol secretion, our findings were consistent with their report, although our patients had been treated and their body weights had recovered. Further study is required to know if the circadian variation of cortisol secretion is conserved in patients with untreated AN in childhood and adolescence. Our study had some limitations and perplexing points. First, the sum of cortisol metabolites in urine might not be the best parameter to analyze the circadian variation of cortisol secretion, considering the possible delayed metabolism of cortisol in AN, especially in untreated and underweight patients. Second, control subjects were young adults, whose ages differed from the patients with AN. Third, the numbers of controls and patients was not enough. Fourth, untreated and underweight patients with AN in childhood and adolescence were not included. Taken together, we are currently trying to increase the number of the control including teenagers and the number of patients including the untreated. Fifth, one patient with AN showed somewhat low sum of cortisol metabolites in the daytime, which may be interpreted as “cortisol hyposecretion”. The reason for this result is unknown and this patient should be followed. In conclusion, the sum of cortisol metabolites in urine by GC/MS in SIM was useful for analyzing the circadian variation of cortisol secretion. Although our data were preliminary, the circadian variation of cortisol secretion may be conserved in patients with AN in childhood and adolescence after recovery of body weight by treatment.
  13 in total

Review 1.  Endocrine aspects of eating disorders in adolescents.

Authors:  Richard L Levine
Journal:  Adolesc Med       Date:  2002-02

Review 2.  A review of endocrine changes in anorexia nervosa.

Authors:  R K Støving; J Hangaard; M Hansen-Nord; C Hagen
Journal:  J Psychiatr Res       Date:  1999 Mar-Apr       Impact factor: 4.791

Review 3.  Early-onset anorexia nervosa and related eating disorders.

Authors:  B Lask; R Bryant-Waugh
Journal:  J Child Psychol Psychiatry       Date:  1992-01       Impact factor: 8.982

4.  Child psychiatry training for pediatricians: Japanese perspectives in infant psychiatry.

Authors:  H Watanabe
Journal:  Psychiatry Clin Neurosci       Date:  1998-12       Impact factor: 5.188

5.  Characterization of the normal temporal pattern of plasma corticosteroid levels.

Authors:  D T Krieger; W Allen; F Rizzo; H P Krieger
Journal:  J Clin Endocrinol Metab       Date:  1971-02       Impact factor: 5.958

6.  Definitive diagnosis of enzymatic deficiencies of steroidogenesis in at-risk newborns and infants by urinary marker analysis using GC/MS-SIM.

Authors:  E M Małunowicz; Z Mitkowska; K Bal; T Nizankowska-Błaz; E Moszczyńska; Z Iwanicka; T E Romer
Journal:  Horm Res       Date:  1997

7.  Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients.

Authors:  P W Gold; H Gwirtsman; P C Avgerinos; L K Nieman; W T Gallucci; W Kaye; D Jimerson; M Ebert; R Rittmaster; D L Loriaux
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

8.  Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates.

Authors:  Keiko Homma; Tomonobu Hasegawa; Eiko Takeshita; Kiyoaki Watanabe; Makoto Anzo; Takio Toyoura; Kazuhiko Jinno; Toya Ohashi; Takashi Hamajima; Yukihiro Takahashi; Takao Takahashi; Nobutake Matsuo
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 9.  Anorexia nervosa in female adolescents: endocrine and bone mineral density disturbances.

Authors:  M T Muñoz; J Argente
Journal:  Eur J Endocrinol       Date:  2002-09       Impact factor: 6.664

10.  A Case of a Preterm Infant with 21-Hydroxylase Deficiency: Implications of the Biochemical Diagnosis with Urinary Pregnanetriolone by Gas Chromatography/Mass Spectrometry in Selected Ion Monitoring (GCMS-SIM).

Authors:  Takashi Hamajima; Shigeru Ohki; Hiroki Imamine; Haruo Mizuno; Keiko Homma; Tomonobu Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2004-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.